1516 related articles for article (PubMed ID: 9365767)
1. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
[TBL] [Abstract][Full Text] [Related]
5. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.
Stolka K; Ndom P; Hemingway-Foday J; Iriondo-Perez J; Miley W; Labo N; Stella J; Abassora M; Woelk G; Ryder R; Whitby D; Smith JS
Cancer Epidemiol; 2014 Apr; 38(2):137-43. PubMed ID: 24631417
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 infection in a Ugandan town on the trans-African highway: prevalence and risk factors.
Nunn AJ; Wagner HU; Okongo JM; Malamba SS; Kengeya-Kayondo JF; Mulder DW
Int J STD AIDS; 1996; 7(2):123-30. PubMed ID: 8737337
[TBL] [Abstract][Full Text] [Related]
8. Antibody to the AIDS virus in Kaposi's sarcoma in Nigeria.
Otu AA
J Surg Oncol; 1988 Mar; 37(3):152-5. PubMed ID: 3162540
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association.
Kempf W; Adams V; Pfaltz M; Briner J; Schmid M; Moos R; Hassam S
Hum Pathol; 1995 Aug; 26(8):914-9. PubMed ID: 7635454
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitudes and practices concerning AIDS in Ugandans.
Konde-Lule JK; Berkley SF; Downing R
AIDS; 1989 Aug; 3(8):513-8. PubMed ID: 2508712
[TBL] [Abstract][Full Text] [Related]
13. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda.
Newton R; Ziegler J; Beral V; Mbidde E; Carpenter L; Wabinga H; Mbulaiteye S; Appleby P; Reeves G; Jaffe H;
Int J Cancer; 2001 Jun; 92(5):622-7. PubMed ID: 11340563
[TBL] [Abstract][Full Text] [Related]
14. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
Otu AA
J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; PristerĂ R; Aiuti F; Ortona L; Ensoli B
J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
[TBL] [Abstract][Full Text] [Related]
17. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in sexually transmitted diseases: is Kaposi's sarcoma a sexually transmitted disease?
Felman YM
Cutis; 1990 Oct; 46(4):303-6. PubMed ID: 2261787
[TBL] [Abstract][Full Text] [Related]
19. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.
Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW
Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145
[TBL] [Abstract][Full Text] [Related]
20. Risk of Kaposi's sarcoma and oroanal sexual contact.
Grulich AE; Kaldor JM; Hendry O; Luo K; Bodsworth NJ; Cooper DA
Am J Epidemiol; 1997 Apr; 145(8):673-9. PubMed ID: 9125993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]